There is 1 paper on CD63+ neutrophil subsets in aging research: none in people yet, 1 in cells.
1 paper studies it1 finding
1 new paper in 30 daysSee all 1 papers on CD63+ neutrophil subsets
- Cells1
Interventions
1Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine
downin human cells1
1 study
Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine
downin human cells1
Arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine decreases CD63+ neutrophil subsets in human cells (chronic obstructive pulmonary disease).
“After incubation with arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine, an increase in the neutrophil granulocyte subset CD63-CD16brightCD62LbrightCD11bbright was observed, while the CD63+CD16brightCD62LbrightCD11bbright and CD63+CD16brightCD62LdimCD11bbright neutrophil subsets were reduced.”
Cellschronic obstructive pulmonary diseaseperipheral blood neutrophilic granulocytes
Russian Journal of Immunology
Latest
1 paper in 12 monthsRussian Journal of Immunology
In vitro effects of synthetic immunotropic hexapeptides on CD63-CD16+CD62L+CD11b+ and CD63+CD16+CD62L+CD11b+ neutrophilic granulocytes in elderly and senile patients with chronic obstructive pulmonary disease
Experiments in human cellsChronic obstructive pulmonary disease